Slovakia will approve Tesla's autonomous driving technology
路透社2026/10/08 10:46Reuters, October 8 – Slovakia is expected to approve Tesla’s TSLA.O Full Self-Driving (FSD) system within a few days, according to a video posted Wednesday afternoon on LinkedIn by Transport Minister Jozef Ráž. This move will make Slovakia the ninth EU country to approve this driver-assistance technology. "Data shows these vehicles reduce accident rates, and that is our goal," he stated. Ráž said the ministry would send a letter of recognition to the Netherlands, where the Dutch regulator RDW approved the system earlier this year and acts as the main supervisory body for Tesla’s European approval process. "Once this letter is delivered, the FSD system can also be used here. But remember: you are still the driver and remain responsible for the vehicle. We do this for your safety," Ráž said in the video. The minister's comments closely followed a Reuters report detailing how Tesla lobbied for FSD approval in Europe by framing regulators as barriers to advancing road safety technology. Several European countries, including the Czech Republic, Slovenia, and Denmark, have approved the use of the system earlier this year. An EU-wide vote on FSD could take place as early as December. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translation may be incorrect or may not provide the necessary context, Reuters does not guarantee the accuracy of automated translation and provides it purely as a convenience for readers. Reuters assumes no responsibility for any damage or loss caused by use of automated translations.)
Reuters, October 8 - Slovakia is expected to approve Tesla's TSLA.O Full Self-Driving (link) (FSD) system within days, Transport Minister Jozef Raz said in a video posted on LinkedIn on Wednesday afternoon. This move will make Slovakia the ninth EU country to approve the driver assistance technology.
"Data show that these cars have reduced accident rates, and that is exactly our goal," he said.
Raz stated that the ministry will send a letter of recognition to the Netherlands, where the Dutch RDW regulator approved (link) the system earlier this year and serves as Tesla's main supervisory authority in the European approval process (link).
"Once this letter is delivered, the FSD system can also be put into use here. But remember: you are still the driver and are responsible for the vehicle. We are doing this for you," Raz said in the video.
The minister's remarks come shortly after a Reuters report (link) detailed how Tesla has been pressuring European regulators to approve the FSD system by portraying regulators as obstacles to improving road safety technologies.
Several European countries, including the Czech Republic (link), Slovenia (link), and Denmark (link), have approved the system for use earlier this year.
An EU-wide vote on FSD could be held as early as December (link).
(To facilitate non-native English speakers, Reuters has automated the translation of its reports into several other languages. Because automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of the automated text and provides these translations merely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CleanTech Lithium expands foothold in Argentina
BUZZ-Better Home & Finance shares rise after announcing a $30 million stock buyback plan
October 8 - Better Home & Finance (BETR.O), a mortgage and home equity financing company, saw its stock price rise 3.8% to $10.30 in pre-market trading after announcing a share repurchase plan. BETR stated that its board of directors has approved a stock buyback program of up to $30 million, with an initial phase of $10 million to kick off the repurchase. The company plans to adjust the pace of the repurchase based on realized operational cost savings and asset disposal progress, such as the proposed sale of its UK bank subsidiary. The buyback program is set to expire on October 8, 2027. In August, BETR forecasted that its Q3 revenue would be below Wall Street expectations as it focuses on partnership opportunities and accelerating the development of its home equity credit business. As of the previous trading day's close, the company's market capitalization was approximately $175 million. As of Wednesday, the stock has dropped about 70% year-to-date. According to LSEG data, seven out of eight analysts rate the stock as "strong buy" or "buy," with one rating it as "hold"; the median target price is $25. (For the convenience of non-English speakers, Reuters provides translated automated reports in several other languages. As automated translations may contain errors or lack required context, Reuters does not guarantee the accuracy of these texts and provides them simply for convenience. Reuters accepts no liability for any damage or loss arising from the use of automated translation.)
Fed Governor Waller leaves room for hawkishness: More rate hikes are needed to support inflation decline, not necessarily on a monthly basis.
Federal Reserve Governor Waller stated that if the data meets expectations, there will be further interest rate hikes. The core PCE year-on-year rate at 3% is still too high, and the recent monetary policy focus remains on fighting inflation.
Updated: Viatris will acquire pain therapy manufacturer Pacira BioSciences for 1.65 billions dollars.
The second paragraph adds stock information, while the fifth, eighth, and ninth paragraphs provide additional details. Background information is supplemented in the sixth, seventh, tenth, and eleventh paragraphs. Reuters, October 8 – Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences (PCRX.O) in an all-cash deal worth $1.65 billions, adding two non-opioid painkillers to its portfolio, the companies said on Thursday. Viatris will acquire Pacira at $36.50 per share, representing a 44.8% premium to the latest closing price. Pacira’s stock rose by 44% in premarket trading. Pacira’s non-opioid painkillers, Exparel and Zilretta, generated sales in 2025 of $575.1 millions and $116.6 millions respectively. Exparel is used to relieve acute pain after surgery, and Zilretta is used to treat pain associated with knee osteoarthritis. Viatris stated it expects to expand the reach of these products in selected target markets. Viatris CEO Scott Smith stated, “the addition of these medications creates a synergy with our rapid-acting meloxicam market opportunities, positioning us as a leader in non-opioid pain management.” The US Food and Drug Administration (FDA) is expected to make a decision by December 27 on the approval application for rapid-acting meloxicam for the treatment of moderate to severe acute pain. Viatris plans to finance the acquisition primarily with idle cash, and the remainder through short-term borrowing. The company noted the deal will have minimal impact on its total leverage ratio. In August, Viatris (link) raised its annual adjusted profit forecast, counting on strong brand drug sales and growth in the Chinese market. The pharmaceutical company had previously faced (link) production setbacks in its Indian operations, including a fire at its Nashik plant in western India and increased competition in the generic drug market, raising concerns about the resilience and growth of its core business. The company stated the transaction is expected to close by the end of 2026 and will immediately enhance Viatris’s financial guidance metrics. (For non-native English speakers, Reuters provides automated translations of its reports into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them for convenience only. Reuters accepts no liability for any damage or loss caused by the use of automated translation.)
Crypto prices
More
